“…Nevertheless, at least a minimal debate is still ongoing on an accurate decision on N/L whether it is a biomarker in discrimination of malignity or not. Exempligratia, we reported that N/L was not a convenient and favorable biomarker in forecasting thyroid malignancy 18 in thyroidology [19][20][21][22][23][24][25][26][27][28][29] . Of note, N/L, particularly in the thyroid with head and neck providers, the growing spectrum of clinical management for challenging conditions remains, especially for thyroidologists and thyroid health as different peas in a pod.…”